Menu Back to DIA-NiFDS-Workshop-2021-Facilitating-the-Development-and-Regulations-of-Covid-19-Vaccines-and-Treatments-Current-Trends-in-New-Drug-Development-and-Regulations

Overview

Click Here to View the Flyer

In response to the continuing COVID-19 crisis, regulatory authorities have focused on providing support for the rapid development of vaccines and treatments and the expedited approval and implementation of agile regulatory systems.

The NIFDS-DIA Workshop 2021 will explore the theme of “Facilitating the Development and Regulations of COVID-19 Vaccines and Treatments / Current Trends in New Drug Developments and Regulations.”

Who should attend?

  • Industry professionals in Pharmaceuticals involved in Research & Development, Regulatory Affairs, Medical Affairs and Clinical Studies
  • Regulators and personnel from Health Authorities and Ministries
  • Academia and Researchers

Learning objectives

NIFDS and DIA jointly offer you an opportunity to share experiences of systematic and effective response to the global crisis caused by the COVID-19 pandemic. We will invite former and current regulators in the FDA and EMA as well as experts from the pharmaceutical industry who have hands-on experiences.

We will also hear from speakers about innovative drug development, tools used and legal strategies.

Program Committee

  • Hae-Young  Ahn, PhD
    Hae-Young Ahn, PhD President
    Ahn Bio, United States
  • So Hee  Kim
    So Hee Kim Director
    NIFDS, Korea, Republic of
  • Younglim  Kim, PhD
    Younglim Kim, PhD Director
    NIFDS, Korea, Republic of
  • Jeewon  Joung, PhD
    Jeewon Joung, PhD Deputy Director
    Korean Ministry of Food and Drug Safety (MFDS) , Korea, Republic of
  • Junesik  Mune, MD, PhD
    Junesik Mune, MD, PhD VP, Clinical & Regulatory Affairs Center
    LG Chem, Korea, Republic of
  • Rok  Song
    Rok Song Research Scientist
    IVI, Korea, Republic of
  • Kyung Won  Seo
    Kyung Won Seo Director General, National Institute of Food and Drug Safety Evaluation
    Ministiry of Food and Drug Safety, Korea, Republic of
  • Younjoo  Park
    Younjoo Park Director, General of Department
    MFDS, Korea, Republic of
  • In-sook  Park
    In-sook Park Director, Gastroenterology and Metabolism Product Div, Drug Evaluation Dept
    Ministry of Food and Drug Safety, Korea, Republic of
Load More

Contact us

Please contact DIA Japan for further information.

Send Email
+81.3.6214.0574

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download